Head Topics

Spravato News

Latest News On Spravato

FDA Approves Stand-Alone Ketamine Nasal Spray for Treatment-Resistant Depression

FDA Approves Stand-Alone Ketamine Nasal Spray for Treatment-Resistant Depression

1/31/2025 1:25 PM
FDA Approves Esketamine Nasal Spray as Standalone Treatment for Major Depressive Disorder

FDA Approves Esketamine Nasal Spray as Standalone Treatment for Major Depressive Disorder

1/24/2025 2:49 PM
Spravato Becomes First Standalone Treatment for Severe Depression in the U.S.

Spravato Becomes First Standalone Treatment for Severe Depression in the U.S.

1/24/2025 1:12 PM
Spravato Nasal Spray Approved as Standalone Treatment for Severe Depression

Spravato Nasal Spray Approved as Standalone Treatment for Severe Depression

1/24/2025 9:51 AM
Spravato Approved as Standalone Treatment for Treatment-Resistant Depression

Spravato Approved as Standalone Treatment for Treatment-Resistant Depression

1/23/2025 8:24 PM
FDA Approves First Nasal Spray Treatment for Major Depressive Disorder

FDA Approves First Nasal Spray Treatment for Major Depressive Disorder

1/23/2025 7:41 PM
Johnson & Johnson's Spravato Approved as Standalone Treatment for Depression and PTSD

Johnson & Johnson's Spravato Approved as Standalone Treatment for Depression and PTSD

1/23/2025 11:31 AM
Ketamine Nasal Spray Approved as Standalone Treatment for Depression

Ketamine Nasal Spray Approved as Standalone Treatment for Depression

1/23/2025 9:32 AM
FDA Approves First-of-Its-Kind Nasal Spray for Treatment-Resistant Depression

FDA Approves First-of-Its-Kind Nasal Spray for Treatment-Resistant Depression

1/22/2025 4:52 PM
FDA Approves First Standalone Treatment for Treatment-Resistant Depression

FDA Approves First Standalone Treatment for Treatment-Resistant Depression

1/22/2025 9:44 AM
FDA Approves Johnson & Johnson's Ketamine Nasal Spray for Severe Depression

FDA Approves Johnson & Johnson's Ketamine Nasal Spray for Severe Depression

1/21/2025 10:21 PM
FDA Approves First Standalone Treatment for Severe Depression

FDA Approves First Standalone Treatment for Severe Depression

1/21/2025 7:58 PM
Johnson & Johnson's Spravato Approved as First Standalone Therapy for Treatment-Resistant Depression

Johnson & Johnson's Spravato Approved as First Standalone Therapy for Treatment-Resistant Depression

1/21/2025 6:40 PM
FDA Approves Spravato as Standalone Treatment for Depression

FDA Approves Spravato as Standalone Treatment for Depression

1/21/2025 6:09 PM
FDA Approves First Nasal Spray for Major Depressive Disorder

FDA Approves First Nasal Spray for Major Depressive Disorder

1/21/2025 2:43 PM
Johnson & Johnson's Nasal Spray Spravato Approved as Standalone Treatment for Treatment-Resistant Depression

Johnson & Johnson's Nasal Spray Spravato Approved as Standalone Treatment for Treatment-Resistant Depression

1/21/2025 10:29 AM
Johnson & Johnson's Spravato Approved as Standalone Treatment for Treatment-Resistant Depression

Johnson & Johnson's Spravato Approved as Standalone Treatment for Treatment-Resistant Depression

1/21/2025 8:39 AM

Williams shares gift to support UTSA at Hall of Fame induction

10/19/2024 6:04 AM


Render Time: 2025-02-14 05:07:03